$92.3 Million is the total value of UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's 39 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BRO | Exit | BROWN & BROWN, INC | $0 | – | -753 | -100.0% | -0.04% | – |
| NKE | Exit | NIKE INC | $0 | – | -400 | -100.0% | -0.05% | – |
| DHR | Exit | DANAHER CORP | $0 | – | -245 | -100.0% | -0.06% | – |
| SRE | Exit | SEMPRA ENERGY | $0 | – | -537 | -100.0% | -0.07% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -837 | -100.0% | -0.07% | – |
| ACWI | Exit | ISHARES MSCI ACWI ETFinvestment funds, public markets-global equity | $0 | – | -1,106 | -100.0% | -0.09% | – |
| ORCL | Exit | ORACLE CORPORATION | $0 | – | -1,503 | -100.0% | -0.09% | – |
| HD | Exit | HOME DEPOT INC/THE | $0 | – | -350 | -100.0% | -0.10% | – |
| DIS | Exit | WALT DISNEY CO/THE | $0 | – | -800 | -100.0% | -0.10% | – |
| IAU | Exit | ISHARES GOLD TRUSTinvestment funds, public markets-global equity | $0 | – | -6,400 | -100.0% | -0.12% | – |
| PHR | Exit | PHREESIA INC | $0 | – | -15,351 | -100.0% | -0.51% | – |
| CHRS | Exit | COHERUS BIOSCIENCES INC | $0 | – | -41,036 | -100.0% | -0.78% | – |
| CSTL | Exit | CASTLE BIOSCIENCES INC | $0 | – | -245,527 | -100.0% | -13.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| TEXAS INSTRUMENTS INC | 41 | Q3 2023 | 31.2% |
| PORTLAND GENERAL ELECTRIC CO | 38 | Q3 2023 | 0.0% |
| LEXICON PHARMACEUTICALS INC | 33 | Q3 2023 | 1.7% |
| AEGLEA BIOTHERAPEUTICS INC | 27 | Q2 2023 | 11.0% |
| APOLLO ENDOSURGERY INC | 24 | Q1 2023 | 5.6% |
| PLX PHARMA INC | 23 | Q1 2023 | 1.7% |
| VANGUARD MSCI EMERGING MKTS | 22 | Q2 2019 | 10.3% |
| VANGUARD ENERGY ETF | 22 | Q2 2019 | 8.7% |
| VANGUARD S&P 500 ETF | 21 | Q3 2023 | 11.8% |
| VANGUARD MSCI EAFE ETF | 20 | Q2 2019 | 13.1% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Taysha Gene Therapies, Inc. | September 24, 2021 | 1,156,255 | 3.0% |
| ZIOPHARM ONCOLOGY INC | February 12, 2016 | 9 | 0.0% |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4/A | 2024-05-14 |
| 4 | 2024-05-01 |
| 3 | 2024-04-30 |
| 13F-HR | 2024-04-30 |
| 144 | 2024-04-29 |
| SC 13G | 2024-03-05 |
| 13F-HR | 2024-02-28 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-04 |
View UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.